Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified
ICD-10 F13.239 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified.
F13.239 refers to a condition characterized by the dependence on sedative, hypnotic, or anxiolytic substances, accompanied by withdrawal symptoms. This diagnosis is applicable when an individual has developed a tolerance to these substances, leading to increased consumption to achieve the desired effects. Withdrawal symptoms may include anxiety, insomnia, tremors, and seizures, which can occur when the substance is reduced or discontinued. The unspecified nature of this code indicates that the specific substance causing the dependence is not documented, making it crucial for healthcare providers to ensure thorough documentation of the patient's substance use history. Treatment often involves a combination of medical detoxification, psychological support, and rehabilitation programs tailored to the individual’s needs. Understanding the nuances of this diagnosis is essential for effective treatment planning and accurate coding.
Detailed substance use history, withdrawal symptom assessment, and treatment plans.
Patients presenting with withdrawal symptoms after cessation of sedative use.
Ensure accurate documentation of the specific sedative or anxiolytic used.
Mental health evaluations, history of substance use, and treatment response.
Patients with co-occurring anxiety disorders and sedative dependence.
Documenting the interplay between mental health and substance use.
Used during initial evaluations for patients with suspected sedative dependence.
Comprehensive assessment notes and treatment plans.
Addiction specialists should document specific substance use history.
Common withdrawal symptoms include anxiety, insomnia, tremors, seizures, and in severe cases, delirium tremens. The severity and type of symptoms can vary based on the specific sedative or anxiolytic used.
